pyridostigmine bromide has been researched along with pirenzepine in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 11 (61.11) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 1 (5.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Arce, VM; Cella, SG; Locatelli, V; Müller, EE | 1 |
Dieguez, C; Dotti, C; Page, MD; Portioli, I; Scanlon, MF; Valcavi, R; Zini, M | 1 |
Camanni, F; Demislis, K; Ghigo, E; Locatelli, V; Massara, F; Mazza, E; Molinatti, GM; Müller, EE; Tangolo, D | 1 |
Ismail, IS; Miell, JP; Peters, JR; Scanlon, MF | 1 |
Arvat, E; Camanni, F; Deghenghi, R; Di Vito, L; Ghigo, E; Gianotti, L; Imbimbo, BP; Lenaerts, V | 1 |
Attanasio, R; Benini, Z; Chiodini, I; Chiodini, PG; Cozzi, R; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Orlandi, P | 1 |
Ogilvy-Stuart, AL; Shalet, SM; Wallace, WH | 1 |
Ismail, IS; Peters, JR; Scanlon, MF | 1 |
Ambrosio, MR; Degli Uberti, EC; Margutti, A; Portaluppi, F; Rossi, R; Trasforini, G; Valentini, A; Vergnani, L | 1 |
Breyer-Pfaff, U; Eiermann, B; Maier, U; Schumm, F; Sommer, N; Winne, D | 1 |
Müller, EE; Rolla, M | 1 |
Alvarez, R; Diez, N; Gil, MJ; Lizcano, F; Llorente, I; Salvador, J; Sopena, M | 1 |
Buccafusco, JJ; Pauly, JR; Prendergast, MA; Stone, JD; Terry, AV | 1 |
Aguilera, A; Bajo, MA; Díez, JJ; Iglesias, P; Selgas, R | 1 |
Albuquerque, EX; Aracava, Y; Castro, NG; Fawcett, WP; Pereira, EF; Randall, WR; Santos, MD | 1 |
Arvat, E; Benso, A; Broglio, F; Casanueva, FF; Deghenghi, R; Dieguez, C; Ghigo, E; Gottero, C; Prodam, F; van der Lely, AJ | 1 |
Arvat, E; Benso, A; Broglio, F; Destefanis, S; Gauna, C; Ghigo, E; Gottero, C; Hofland, L; Prodam, F; van der Lely, AJ; Van Koetsveld, P | 1 |
4 trial(s) available for pyridostigmine bromide and pirenzepine
Article | Year |
---|---|
Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
Topics: Blood Glucose; Carrier Proteins; Diabetes Mellitus, Type 1; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Male; Pirenzepine; Pyridostigmine Bromide; Stimulation, Chemical; Time Factors | 1995 |
Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
Topics: Adult; Blood Glucose; Cholinesterase Inhibitors; Diabetes Mellitus, Type 1; Feedback; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamus; Male; Middle Aged; Pirenzepine; Pyridostigmine Bromide; Somatostatin | 1993 |
Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis.
Topics: Adult; Area Under Curve; Cholinesterase Inhibitors; Erythropoietin; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Male; Muscarinic Antagonists; Peritoneal Dialysis; Pirenzepine; Pyridostigmine Bromide; Recombinant Proteins; Uremia | 2000 |
Acetylcholine regulates ghrelin secretion in humans.
Topics: Acetylcholine; Adult; Blood Glucose; Cholinesterase Inhibitors; Ghrelin; Human Growth Hormone; Humans; Insulin; Male; Muscarinic Antagonists; Peptide Hormones; Pirenzepine; Pyridostigmine Bromide | 2004 |
14 other study(ies) available for pyridostigmine bromide and pirenzepine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Studies of growth hormone secretion in calorically restricted dogs: effect of cholinergic agonists and antagonists, glucose and thyrotropin-releasing hormone.
Topics: Animals; Blood Glucose; Body Weight; Dogs; Drug Interactions; Energy Intake; Female; Glucose; Growth Hormone; Growth Hormone-Releasing Hormone; Insulin-Like Growth Factor I; Male; Parasympatholytics; Parasympathomimetics; Pirenzepine; Pyridostigmine Bromide; Thyrotropin-Releasing Hormone | 1991 |
Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patients.
Topics: Adolescent; Adult; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hyperthyroidism; Hypothalamus; Male; Pirenzepine; Pituitary Gland; Pyridostigmine Bromide; Secretory Rate | 1991 |
Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
Topics: Acromegaly; Adult; Aged; Atropine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Peptide Fragments; Pirenzepine; Pyridostigmine Bromide; Receptors, Cholinergic; Thyrotropin-Releasing Hormone | 1986 |
Modulation of growth hormone-releasing activity of hexarelin in man.
Topics: Adult; Amino Acid Sequence; Arginine; Evaluation Studies as Topic; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Molecular Sequence Data; Oligopeptides; Pirenzepine; Pyridostigmine Bromide; Somatostatin | 1995 |
Persistence of somatostatinergic tone in acromegaly.
Topics: Acromegaly; Adult; Aged; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Pirenzepine; Pyridostigmine Bromide; Somatostatin | 1995 |
Radiation and neuroregulatory control of growth hormone secretion.
Topics: Adult; Brain Neoplasms; Cranial Irradiation; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Peptide Fragments; Pirenzepine; Pyridostigmine Bromide; Somatostatin | 1994 |
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man.
Topics: Adult; Calcitonin Gene-Related Peptide; Female; Humans; Male; Osmolar Concentration; Parasympathetic Nervous System; Pirenzepine; Pyridostigmine Bromide; Reference Values | 1994 |
Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine.
Topics: Adolescent; Adult; Aged; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Myasthenia Gravis; Pirenzepine; Pyridostigmine Bromide; Ranitidine | 1993 |
Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs.
Topics: Adolescent; Animals; Anorexia Nervosa; Arginine; Cholinergic Fibers; Dogs; Energy Intake; Female; Food Deprivation; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Muscarinic Antagonists; Neurosecretory Systems; Parasympathomimetics; Pirenzepine; Pyridostigmine Bromide; Receptors, Somatostatin | 1996 |
Cholinergic modulation of spontaneous hypothalamic-pituitary-adrenal activity and its circadian variation in man.
Topics: Adrenocorticotropic Hormone; Adult; Cholinesterase Inhibitors; Circadian Rhythm; Drug Combinations; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Muscarine; Parasympathetic Nervous System; Pirenzepine; Pituitary-Adrenal System; Pyridostigmine Bromide | 1996 |
Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats.
Topics: Acetylcholinesterase; Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Isoflurophate; Male; Memory; Pirenzepine; Pyridines; Pyridostigmine Bromide; Rats; Rats, Wistar; Receptors, Cholinergic | 2000 |
Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors.
Topics: Animals; Atropine; Central Nervous System; Cholinesterase Inhibitors; Cholinesterases; Electric Stimulation; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Membrane Potentials; Muscarinic Antagonists; Neurons; Patch-Clamp Techniques; Piperidines; Pirenzepine; Pyramidal Cells; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; Receptors, Nicotinic; Soman; Synaptic Transmission | 2003 |
Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
Topics: Acetylcholine; Adult; Cholinesterase Inhibitors; Drug Interactions; Ghrelin; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Ligands; Male; Muscarinic Antagonists; Peptide Hormones; Pirenzepine; Prolactin; Pyridostigmine Bromide; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Ghrelin | 2003 |